Ori Biotech
Andy Bennett has worked in a variety of roles in the finance and accounting sector since 2006. Andy began their career with a summer internship at Deloitte UK in 2006, followed by a Manager - Audit, Consumer Business role at the same company in 2007. In 2013, they moved to Volex as a Group Accountant, then to Harvey Nash Group as a Group Financial Controller in 2016. In 2019, they were a Group Financial Controller at Synthomer, and is currently a Financial Controller at Ori Biotech since 2022.
Andy Bennett attended the University of Cambridge from 2003 to 2007, where they earned an MSci in Natural Sciences. Andy then attended ICAEW from 2007 to 2009.
Ori Biotech
Ori Biotech is a London- and New Jersey-based innovator in CGT manufacturing that has developed a proprietary, bespoke and flexible manufacturing platform, which enables patient access to a new generation of personalized, life-saving treatments.